Pentobarbital features throughout the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This action potentiates GABA effects, leading to CNS melancholy and inhibiting glutamate, more bringing about an additive impact on CNS despair. Although the not enough an antidote has triggered lessened initial-line use with the drug, its in